Literature DB >> 7938392

Misdiagnosed HIV infection in pregnant women: implications for clinical care.

A R Sheon1, H E Fox, G Alexander, A Buck, A Higgins, S M McDermott, G Moroso, J Moye, E Pacheco-Acosta.   

Abstract

Out of nearly 900 women in a research study of human immunodeficiency virus infection in pregnancy, 8 were subsequently found not to be infected. Misdiagnoses could have resulted from (a) laboratory errors or specimen mixups; (b) failure to follow the testing algorithm recommended by the Centers for Disease Control and Prevention to confirm results; (c) women perceiving they were infected by high-risk behavior in the absence of testing, despite the receipt of negative test results, or based on screening results only; or (d) factitious disorder, HIV Munchausen syndrome, or malingering. Because of the potentially devastating impact of an HIV diagnosis and the toxicity of HIV therapies, health care providers should obtain independent confirmation of the diagnosis before initiating treatment or followup for HIV based on patient report or provider referral. Quality test interpretation and counseling must be ensured. Therapeutic interventions may be indicated for persons intentionally and falsely presenting themselves as HIV-infected.

Entities:  

Mesh:

Year:  1994        PMID: 7938392      PMCID: PMC1403560     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  17 in total

1.  Munchausen AIDS and haemophilia.

Authors:  S N Cottam; A C Cuthbert; L A Parapia
Journal:  Eur J Haematol       Date:  1991-02       Impact factor: 2.997

2.  Munchausen syndrome masquerading as AIDS-induced depression.

Authors:  J McDonald; K Wafer
Journal:  Br J Psychiatry       Date:  1989-03       Impact factor: 9.319

3.  Munchausen AIDS.

Authors:  F C Kavalier
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

4.  Factitious AIDS.

Authors:  S E Nickoloff; V M Neppe; R K Ries
Journal:  Psychosomatics       Date:  1989       Impact factor: 2.386

5.  Screening for HIV: can we afford the false positive rate?

Authors:  K B Meyer; S G Pauker
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

6.  Munchausen's/AIDS.

Authors:  J W Baer
Journal:  Gen Hosp Psychiatry       Date:  1987-01       Impact factor: 3.238

7.  Measurement of the false positive rate in a screening program for human immunodeficiency virus infections.

Authors:  D S Burke; J F Brundage; R R Redfield; J J Damato; C A Schable; P Putman; R Visintine; H I Kim
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

8.  Errors in reporting seropositivity for infection with human immunodeficiency virus (HIV)

Authors:  S D Holmberg; C R Horsburgh; R H Byers; C A Schable; A R Lifson; G R Seage; E E Schoenbaum
Journal:  Ann Intern Med       Date:  1988-10-15       Impact factor: 25.391

9.  Indeterminate human immunodeficiency virus type 1 western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation.

Authors:  C L Celum; R W Coombs; W Lafferty; T S Inui; P H Louie; C A Gates; B J McCreedy; R Egan; T Grove; S Alexander
Journal:  J Infect Dis       Date:  1991-10       Impact factor: 5.226

10.  Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study.

Authors:  C L Celum; R W Coombs; M Jones; V Murphy; L Fisher; C Grant; L Corey; T Inui; M H Wener; K K Holmes
Journal:  Arch Intern Med       Date:  1994-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.